COMPLETED

Yoga Training and Retinal Vasculature

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will compare the impact of a novel high-speed, cued yoga program to a standard yoga program on retinal microvasculature, cognition and neuromuscular function.

Official Title

The Impact of Yoga Training Protocols on Cognition, Aerobic, and Neuromuscular Performances, and Retinal Microvasculature and Microcirculation in Older Persons.

Quick Facts

Study Start:2023-09-01

Study Completion:2025-05-15

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:COMPLETED

Study ID

NCT06099405

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years to 90 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. 60-90 years of age; 2. Montreal Cognitive Assessment (MoCA) \> 23 3. no memory loss complaints	1. uncontrolled cardiovascular or neuromuscular diseases that prevent participation in a training program; 2. cerebrovascular disease; 3. documented HIV infection or other immunodeficiency syndrome; 4. any systemic inflammatory or autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, or other serious concomitant medical illness; 5. a history of ocular surgeries (except for cataract surgery more than 6 months ago) or other ocular diseases; 6. bilateral moderate or severe cataracts; 7. refractive errors of myopia, hyperopia and/or astigmatism more than 6.0 Diopters

Inclusion Criteria

Exclusion Criteria

1. 60-90 years of age;
2. Montreal Cognitive Assessment (MoCA) \> 23
3. no memory loss complaints

1. uncontrolled cardiovascular or neuromuscular diseases that prevent participation in a training program;
2. cerebrovascular disease;
3. documented HIV infection or other immunodeficiency syndrome;
4. any systemic inflammatory or autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, or other serious concomitant medical illness;
5. a history of ocular surgeries (except for cataract surgery more than 6 months ago) or other ocular diseases;
6. bilateral moderate or severe cataracts;
7. refractive errors of myopia, hyperopia and/or astigmatism more than 6.0 Diopters

Contacts and Locations

Principal Investigator

Joseph F. Signorile, PhD

PRINCIPAL_INVESTIGATOR

University of Miami

Study Locations (Sites)

Laboratory of Neruomuscular Research and Active Aging

Coral Gables, Florida, 33147

United States

Collaborators and Investigators

Sponsor: University of Miami

Joseph F. Signorile, PhD, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-01

Study Completion Date2025-05-15

Study Record Updates

Study Start Date2023-09-01

Study Completion Date2025-05-15

Terms related to this study

Additional Relevant MeSH Terms

Cognitive Change